Perkins Capital Management Inc Vivos Therapeutics, Inc. Transaction History

Perkins Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$0.18 - $0.52 $990 - $2,860	-5,500 Reduced 26.83%	15,000 $3,000
Q2 2023 Jul 21, 2023	SELL	$0.31 - $0.55 $620 - $1,100	-2,000 Reduced 8.89%	20,500 $10,000
Q1 2023 May 09, 2023	SELL	$0.32 - $1.88 $9,440 - $55,460	-29,500 Reduced 56.73%	22,500 $8,000
Q4 2022 Jan 26, 2023	SELL	$0.35 - $20.75 $1,575 - $93,375	-4,500 Reduced 7.96%	52,000 $21,000
Q3 2022 Oct 24, 2022	SELL	$0.83 - $21.25 $89,059 - $2.28 Million	-107,300 Reduced 65.51%	56,500 $37,000
Q2 2022 Jul 29, 2022	BUY	$1.12 - $2.18 $15,400 - $29,975	13,750 Added 9.16%	163,800 $211,000
Q1 2022 Apr 20, 2022	BUY	$1.63 - $3.63 $22,820 - $50,820	14,000 Added 10.29%	150,050 $402,000
Q4 2021 Feb 10, 2022	SELL	$2.25 - $4.11 $23,512 - $42,949	-10,450 Reduced 7.13%	136,050 $306,000
Q3 2021 Oct 25, 2021	SELL	$2.71 - $5.9 $43,360 - $94,400	-16,000 Reduced 9.85%	146,500 $592,000
Q2 2021 Jul 28, 2021	BUY	$4.83 - $9.67 $784,875 - $1.57 Million	162,500 New	162,500 $804,000
Q1 2021 Apr 28, 2021	SELL	$6.01 - $8.9 $120,200 - $178,000	-20,000 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$5.91 - $9.11 $118,200 - $182,200	20,000 New	20,000 $118,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.